Contemporary epidemiology and prognosis of septic shock in infective endocarditis

European Heart Journal

Volumn 34, Issue 26, 2013, Pages 1999-2006

  Olmos, Carmen ^a   Vilacosta, Isidre ^a   Fernández, Cristina ^a   López, Javier ^b   Sarriá, Cristina ^c   Ferrera, Carlos ^a   Revilla, Ana ^b   Silva, Jacobo ^a   Vivas, David ^a   González, Isabel ^c   San Román, Joséalberto ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Infective endocarditis; Prognosis; Septic shock

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR MORTALITY; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE COURSE; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERSISTENT INFECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPRAVENTRICULAR TACHYCARDIA; TERTIARY HEALTH CARE; CROSS INFECTION; DIABETES MELLITUS; ECHOCARDIOGRAPHY; MIDDLE AGED; MORTALITY; CLINICAL TRIAL; COMPLICATION;

INFECTIVE ENDOCARDITIS; PROGNOSIS; SEPTIC SHOCK;

ACUTE KIDNEY INJURY; CROSS INFECTION; DIABETES COMPLICATIONS; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 84889664533     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs336     Document Type: Article

References (53)

1. Erbel R, Liu F, Rohmann J, Kupferwasser I. Identification of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur Heart J 1995;16: 588-602.
2. Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002;88: 53-60.
3. Bouza E, Menasalvas A, Mun̈oz P, Vasallo FJ, del Mar Moreno M, Garcia Fernández MA. Infective endocarditis: a prospective study at the end of the twentieth century. Medicine 2001;80:298-307.
4. San Román JA, López J, Vilacosta I, Luaces M, Sarriá C, Revilla A, Ronderos R, Stoermann W, Gómez I, Fernández- Avilés F. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007;120: 369e1-369e7.
5. Chu VH, Cabell ChH, Benjamin DK, Kuniholm EF, Fowler V, Engemann J, Sexton DJ, Corey GR, Wang A. Early predictors of in-hospital deaths in infective endocarditis. Circulation 2004;109:1745-1749.
6. Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults. Risk classification for mortality. JAMA 2003;289:1933-1940.
7. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG Jr; International Collaboration on Endocarditis Merged Database Study Group. Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005;41: 507-514.
8. Delahaye F, Alla F, Beguinot I, Bruneval P, Doco-Lecompte T, Lacassin F, Selton-Suty C, Vandenesch F, Vernet V, Hoen B; AEPEI Group. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007;39:849-857.
9. Kanafani ZA, Kourany WM, Fowler VG, Levine DP, Vigliani GA, Campion M, Katz DE, Corey GR, Boucher HW. Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditis. Eur J Clin Microbiol Infect Dis 2009;28:1477-1482.
10. Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, Hoen B, Habib G, Fowler VG Jr, Sexton DJ, Olaison L, Cabell CH. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis 2006;38:613-619.
11. Galvez-Acebal J, Rodríguez-Ban̈ol J, Martinez-Marcos FJ, Reguera JM, Plata A, Ruiz J. Prognostic factors in left-sided endocarditis: results from the Andalusian Multicenter Cohort. BMC Infect Dis 2010;10:17.
12. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP, Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabró R, Riberi A, Collart F, Metras D, Lepidi H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G. Risk of embolism and death in infective endocarditis: Prognostic value of echocardiography. A prospective multicenter study. Circulation 2005;112:69-75.
13. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century. Arch Intern Med 2009;169:463-473.
14. Mourviller B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Regnier B, Gibert C, Wolff M. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 2004;30: 2046-2052.
15. Heiro M, Helenius H, Hurme S, Savunem T, Engblom E, Nikoskelainen J, Kotilainen P. Short-term and one-year outcome of infective endocarditis in adult patients treated in a Finish teaching hospital during 1980-2004. BMC Infect Diseases 2007;7:78.
16. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30: 2369-2413.
17. Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Lucà F, Carella R, Crudeli E, Rubino A, Rostagno C, Russo C, Borghetti V, Beghi C, De Bonis M, Gensini GF, Lorusso R. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thorac Surg 2012;93:1469-1476.
18. Li JS, Sexton DJ, Mick N, Nettles R, Fowler WG, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.
19. Lopez J, Revilla A, Vilacosta I, Villacorta E, Gonzalez-Juanatey C, Gomez I, Rollan MJ, San Roman JA. Definition, clinical profile, microbiologic spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007;28:760-765.
20. Revilla A, López J, Vilacosta I, Villacorta E, Rollán MJ, Echevarria JR, Carrascal Y, Di Stefano S, Fulquet E, Rodríguez E, Fiz L, San Román JA. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J 2007;28:65-71.
21. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
22. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines forthe diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442.
23. San Román JA, Vilacosta I, Sarria C, de la Fuente L, Sanz O, Vega JL, Ronderos R, Gonzalez Pinto A, Jesus Rollan M, Graupner C, Batlle E, Lahulla F, Stoermann W, Portis M, Fernández-Aviles F. Clinical course, microbiologic profile, and diagnosis of periannular complications in prosthetic valve endocarditis. Am J Cardiol 1999; 83:1075-1079.
24. Graupner C, Vilacosta I, San Román J, Ronderos R, Sarria C, Fernandez C, Mujica R, Sanz O, Sanmartin JV, Pinto AG. Periannular extension of infective endocarditis. J Am Coll Cardiol 2002;39:1204-1211.
25. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W. Recommendations for chamber quantification. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Eur J Echocardiogr 2006;7:79-108.
26. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association. Endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434.
27. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Ki HK, Son JS, Lee SS, Kim YS, Jung SI, Kim SW, Chang HH, Ryu SY, Kwon KT, Lee H, Moon C; Korean Network for Study of Infectious Diseases (KONSID). Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect 2011;62:26-33.
28. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 2003;168: 165-172.
29. Pittet D, Thievent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of preexisting co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993;19:265-272.
30. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, Linde-Zwirble W. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004;8:R291-R298.
31. Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, Valfrè C, Olivari Z. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis 2010;19:312-320.
32. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999;341:1906-1912.
33. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001;15: 407-421.
34. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med 2004;32: 992-997.
35. Munford RS, Suffredini AF. Sepsis, severe sepsis, and septic shock. In Mandell GL, Bennett JE, Dolin R eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p987-1010.
36. Leibovici L, Drucker M, Konigsberger H, Samra Z, Harrari S, Ashkenazi S, Pitlik SD. Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis 1997;29:71-75.
37. Mansur AJ, Grinberg M, Cardoso RH, da Luz PL, Bellotti G, Pileggi F. Determinants of prognosis in 300 episodes of infective endocarditis. Thorac Cardiovasc Surg 1996;44:2-10.
38. Woo KS, Lam YM, Kwok HT, Tse LK, Vallance-Owen J. Prognosis index in prediction of mortality from infective endocarditis. Int J Cardiol 1989;24:47-54.
39. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007;28:196-203.
40. Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, Eckardt KU, Loeffler M, John S; German Competence Network Sepsis (Sepnet). Acute renal failure in patients with severe sepsis and septic shock - a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant 2008;23:904-909.
41. Majumdar A, Chowdhary S, Ferreira MA, Hammond LA, Howie AJ, Lipkin GW, Littler WA. Renal pathological findings in infective endocarditis. Nephrol Dial Trasplant 2000;15:1782-1787.
42. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol 1998;49:96-101.
43. Erbay AR, Erbay A, Canga A, Keskin G, Sen N, Atak R, Demir AD, Balbay Y, Duru E. Risk factors for in-hospital mortality in infective endocarditis: five years' experience at a tertiary care hospital in Turkey. J Heart Valve Dis 2010; 19:216-224.
44. Karth G, Koreny M, Binder T, Knapp S, Zauner C, Valentin A, Honninger R, Heinz G, Siostrzonek P. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care 2002;6:149-154.
45. Goodman S, Shirov T, Weissman C. Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences. Anesth Analg 2007;104: 880-886.
46. Goodman S, Weiss Y, Weissman C. Update on cardiac arrhythmias in the ICU. Curr Opin Crit Care 2008;14:549-554.
47. Bender JS. Supraventricular tachyarrhythmias in the surgical intensive care unit: an under-recognized event. Am Surg 1996;62:73-75.
48. Luaces M, Vilacosta I, Fernández C, Sarriá C, San Román JA, Graupner C, Nun̈ez-Gil IJ. Vegetation size at diagnosis in infective endocarditis: influencing factors and prognostic implications. Int J Cardiol 2009;137:76-78.
49. Munford RS. Severe sepsis and septic shock: the role of gram-negative bacteremia. Ann Rev Pathol 2006;1:467-496.
50. Jimenez MF, Marshall JC. Source control in the management of sepsis. Intensive Care Med 2001;27:S49-S62.
51. Vincent JL, Sakr Y, Sprung CL, Ranieri M, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-353.
52. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995;74:324-339.
53. Tornos MP, Permanyer-Miralda G, Olona M, Gil M, Galve E, Almirante B, Soler-Soler J. Long term complications of native valve infective endocarditis in non addicts. A 15-year follow-up study. Ann Intern Med 1992;117:567-572.